OXYSTEROL THERAPEUTICS Trademark

Trademark Overview

On Thursday, September 3, 2015, a trademark application was filed for OXYSTEROL THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the OXYSTEROL THERAPEUTICS trademark a serial number of 86746639. The federal status of this trademark filing is REGISTERED as of Tuesday, February 28, 2017. This trademark is owned by MAX BioPharma, Inc.. The OXYSTEROL THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Therapeutic pharmaceutical for the treatment of osteoporosis, localized bone formation conditions, for use in oncology
oxysterol therapeutics

General Information

Serial Number86746639
Word MarkOXYSTEROL THERAPEUTICS
Filing DateThursday, September 3, 2015
Status700 - REGISTERED
Status DateTuesday, February 28, 2017
Registration Number5152047
Registration DateTuesday, February 28, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 1, 2016

Trademark Statements

Goods and ServicesTherapeutic pharmaceutical for the treatment of osteoporosis, localized bone formation conditions, for use in oncology
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 9, 2015
Primary Code005
First Use Anywhere DateSaturday, April 30, 2011
First Use In Commerce DateSaturday, April 30, 2011

Trademark Owner History

Party NameMAX BioPharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90049
Party NameMAX BioPharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90049
Party NameMAX BioPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90049

Trademark Events

Event DateEvent Description
Wednesday, December 16, 2015ASSIGNED TO EXAMINER
Monday, September 7, 2015NEW APPLICATION ENTERED
Wednesday, September 9, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 1, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, December 18, 2015NON-FINAL ACTION WRITTEN
Friday, December 18, 2015NON-FINAL ACTION E-MAILED
Friday, December 18, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 29, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 29, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 30, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 4, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 10, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 1, 2016PUBLISHED FOR OPPOSITION
Thursday, January 19, 2017ASSIGNED TO LIE
Tuesday, April 26, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 31, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, May 31, 2016USE AMENDMENT FILED
Thursday, June 23, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 24, 2016STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 29, 2016SU - NON-FINAL ACTION - WRITTEN
Wednesday, June 29, 2016NON-FINAL ACTION E-MAILED
Wednesday, June 29, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 19, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 29, 2023TEAS SECTION 7 REQUEST RECEIVED
Thursday, January 19, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 19, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 23, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 24, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, January 25, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 25, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 28, 2017REGISTERED-PRINCIPAL REGISTER
Monday, February 28, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, August 25, 2023TEAS SECTION 8 RECEIVED
Thursday, September 26, 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Monday, April 15, 2024POST REGISTRATION ACTION MAILED - SEC. 7
Monday, April 8, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Related Keywords

therapeutics oxysterol formation conditions oncology bone localized pharmaceutical treatment osteoporosis therapeutic